Cheng Zhang

Cheng Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
UBUmberto Maria Battisti
Umberto Maria Battisti
CGChunixa Gao
Chunixa Gao
FAFady Akladios
Fady Akladios
WKWoonghee Kim
Woonghee Kim
HYHong Yang
Hong Yang
MGMorten Grøtli
Morten Grøtli
Liver pyruvate kinase (PKL) has recently emerged as a new target for non-alcoholic fatty liver disease (NAFLD), and inhibitors of this enzyme could represent a new therapeutic option. However, this breakthrough is complicated by selectivity issues since pyruvate kinase exists in four different isoforms. In this work, we report that ellagic acid (EA) and its derivatives, present in numerous fruits and vegetables, can inhibit PKL potently and selectively. Several polyphenolic analogues of EA were synthesized and tested to identify the chemical features responsible for the desired activity. Molecular modelling studies suggested that this inhibition is related to the stabilization of the PKL inactive state. This unique inhibition mechanism could potentially herald the development of new therapeutics for NAFLD.

3 June 2025 in Genome Biology
Verified
Journal Article
Open access
PDF file
MSMengnan Shi
Mengnan Shi
LMLoren Méar
Loren Méar
MKMax Karlsson
Max Karlsson
MÁMaría Bueno Álvez
María Bueno Álvez
ADAndreas Digre
Andreas Digre
CZCheng Zhang
Cheng Zhang
New technologies enable single-cell transcriptome analysis, mapping genome-wide expression across the human body. Here, we present an extended analysis of protein-coding genes in all major human tissues and organs, combining single-cell and bulk transcriptomics. To enhance transcriptome depth, 31 tissues were analyzed using a pooling method, identifying 557 unique cell clusters, manually annotated by marker gene expression. Genes were classified by body-wide expression and validated through antibody-based profiling. All results are available in the updated open-access Single Cell Type section of the Human Protein Atlas for genome-wide exploration of genes, proteins, and their spatial distribution in cells.

5 April 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
OAOzlem Altay
Ozlem Altay
CZCheng Zhang
Cheng Zhang
Hasan TurkezHasan Turkez
Hasan Turkez
JNJens Nielsen
Jens Nielsen
MUMathias Uhlen
Mathias Uhlen
AMAdil Mardinoglu
Adil Mardinoglu
Burkholderia cenocepacia is among the important pathogens isolated from cystic fibrosis (CF) patients. It has attracted considerable attention because of its capacity to evade host immune defenses during chronic infection. Advances in systems biology methodologies have led to the emergence of methods that integrate experimental transcriptomics data and genome-scale metabolic models (GEMs). Here, we integrated transcriptomics data of bacterial cells grown on exponential and biofilm conditions into a manually curated GEM of B. cenocepacia. We observed substantial differences in pathway response to different growth conditions and alternative pathway susceptibility to extracellular nutrient availability. For instance, we found that blockage of the reactions was vital through the lipid biosynthesis pathways in the exponential phase and the absence of microenvironmental lysine and tryptophan are essential for survival. During biofilm development, bacteria mostly had conserved lipid metabolism but altered pathway activities associated with several amino acids and pentose phosphate pathways. Furthermore, conversion of serine to pyruvate and 2,5-dioxopentanoate synthesis are also identified as potential targets for metabolic remodeling during biofilm development. Altogether, our integrative systems biology analysis revealed the interactions between the bacteria and its microenvironment and enabled the discovery of antimicrobial targets for biofilm-related diseases.